Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34
2. Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 37(18):1558–1565
3. Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 18:2051–2058
4. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, (editors) (2002) AJCC cancer staging manual. Sixth edition. New York: Springer
5. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, (editors) (2010) AJCC cancer staging manual. Seventh edition. New York: Springer